PLENCIFGENE PARVEC
UNII 9SG6QLJ7VJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Plencifgene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9SG6QLJ7VJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2737363-32-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
9SG6QLJ7VJ
CAS Registry Number
2737363-32-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PLENCIFGENE PARVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C221002
National Cancer Institute reference terminology for clinical and research data.
INN ID
13321
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
OP-05
Identifier assigned by the United States Adopted Names Council.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Plencifgene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PLENCIFGENE PARVEC

Common Names & Synonyms

4D-A101.CMV173-CFTR.DELTA.R
PLENCIFGENE PARVEC [INN]
PLENCIFGENE PARVEC [USAN]
RECOMBINANT REPLICATION-DEFECTIVE ADENO-ASSOCIATED VIRUS VECTOR 4D-710 CYTOMEGALOVIRUS PROMOTER CMV173 PLUS HUMAN (1-707)-(760-1480)-CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CODON-OPTIMIZED GENE CFTR.DELTA.R PLUS SYNTHETIC POLYADENYLATION SIGNAL PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FLANKS-SPECIFYING
RECOMBINANT, NON-REPLICATING ADENO-ASSOCIATED VIRUS (AAV) VECTOR (WITH CAPSID VARIANT A101) ENCODING CODON-OPTIMISED HUMAN CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) WITH THE REGULATORY DOMAIN DELETED (CFTR.DELTA.R), UNDER CONTROL OF A 173BP CYTOMEGALOVIRUS (CMV173) MINIMAL PROMOTER AND A SHORT SYNTHETIC POLYADENYLATION SIGNAL; FLANKED BY AAV2 INVERTED TERMINAL REPEATS. THE VARIANT A101 CAPSID IS A CHIMERA CONSISTING PRIMARILY OF SEROTYPE AAV1 BUT ALSO INCLUDIN

Technical Codes

4D-710

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus